Uploaded January 2024 | Updated September 2026, 3 weeks ago

---

Linked videos:
Previous Bryan Johnson video:
youtu.be/Xpum1OmUVKQ
PFS syndrome:
youtu.be/CS9D5RVO3J0
youtu.be/tx8c3BvfuWw
youtu.be/dXwO0E2A7LI
youtu.be/YM4DJbK9HQY
youtu.be/kHhxHtKGmBo
youtu.be/PVLJMwUFDvI
youtu.be/ykk3UVyeCiA
youtu.be/iDeDcBg4esk

Sources:
1. Key Statistics for Bladder Cancer. Accessed January 13, 2024. cancer.org/cancer/types/bladder-cancer/about/key-statistics.html
2. Morales EE, Grill S, Svatek RS, et al. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. Eur Urol. 2016;69(3):407-410. doi:10.1016/j.eururo.2015.08.029
3. Gil D, Zarzycka M, Dulińska-Litewka J, Ciołczyk-Wierzbicka D, Lekka M, Laidler P. Dihydrotestosterone increases the risk of bladder cancer in men. Hum Cell. 2019;32(3):379-389. doi:10.1007/s13577-019-00255-3
4. Kharroubi SA, Diab-El-Harake M. Sex-differences in COVID-19 diagnosis, risk factors and disease comorbidities: A large US-based cohort study. Front Public Health. 2022;10:1029190. doi:10.3389/fpubh.2022.1029190
5. Chen J, Huang CP, Quan C, et al. The androgen receptor in bladder cancer. Nat Rev Urol. 2023;20(9):560-574. doi:10.1038/s41585-023-00761-y
6. Garg H, Wheeler KM, Dursun F, et al. Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis. Clin Genitourin Cancer. 2023;21(2):314.e1-314.e7. doi:10.1016/j.clgc.2022.10.014